Now out in @EJCI_News
Logan Powell & I show where randomized trials necessary
When people say 'we don't need an RCT of smoking (to prove harm) or parachutes (to prove benefit)' does that apply to widespread medical interventions?
🧵 onlinelibrary.wiley.com/doi/10.1111/ec…
Led by Timothee Olivier, our new paper is now out at @JAMANetworkOpen
We analyze 12 years of FDA approvals, and do the hard work of sorting them into
New Mechanism of Action (MOA)
& New MOA for that tumor type
Vs next in class
Few prelim thoughts on this trial (from quick read) #ASH21 1. It is not a 'second line' trial, it is a trial in the worst subset of second line pts & cannot extrapolate beyond
Primary refractory & relapse <12 mo
(TBH, a lot of people doing this already)
As such, it should not generalize to relapse > 12 months
2. That said, for those included, axi-cel seems preferable to chemo then auto; I am not surprised this is true in the most chemo insensitive biology. But a few more thoughts
3. This is Wrong, you are not supposed to do this 👇👇
Standard practice is to take these pts to CAR-T if needed in the control arm; thus, you must compare routine, upfront CAR-T to using CAR-T as salvage when indicated and standard of care.
... many of these people who are losing their jobs right now risk their own personal safety to work in the hospital before there was a vaccine. When you needed them.
These people don't disappear from America either, and their fate is tied to all our fate.
Pressuring people to get vaccinated will increase vaccination rate some fraction and that will provide some marginal extra protection to people who've already chosen to be vaccinated, but it will also lead to firings and that will provide negative countervailing results..